Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival.

× No keyword cloud information.

16 in total

1. YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).

Authors: Jason W Lui; Stephen P G Moore; Lee Huang; Kelsey Ogomori; Yan Li; Deborah Lang
Journal: Pigment Cell Melanoma Res Date: 2021-09-01 Impact factor: 4.693

2. Inactivation of the Hippo tumor suppressor pathway promotes melanoma.

Authors: Marc A Vittoria; Nathan Kingston; Kristyna Kotynkova; Eric Xia; Rui Hong; Lee Huang; Shayna McDonald; Andrew Tilston-Lunel; Revati Darp; Joshua D Campbell; Deborah Lang; Xiaowei Xu; Craig J Ceol; Xaralabos Varelas; Neil J Ganem
Journal: Nat Commun Date: 2022-06-29 Impact factor: 17.694

Review 3. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine.

Authors: Iván M Moya; Georg Halder
Journal: Nat Rev Mol Cell Biol Date: 2019-04 Impact factor: 94.444

Review 4. YAP/TAZ at the Roots of Cancer.

Authors: Francesca Zanconato; Michelangelo Cordenonsi; Stefano Piccolo
Journal: Cancer Cell Date: 2016-06-13 Impact factor: 31.743

5. LKB1 Tumor Suppressor: Therapeutic Opportunities Knock when LKB1 Is Inactivated.

Authors: Wei Zhou; Jun Zhang; Adam I Marcus
Journal: Genes Dis Date: 2014-09-01

6. Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cells.

Authors: Sung-Min Hwang; MeiHong Jin; Yong Hwan Shin; Seul Ki Choi; Eun Namkoong; MinKyoung Kim; Moon-Yong Park; Kyungpyo Park
Journal: Exp Mol Med Date: 2014-12-12 Impact factor: 8.718

7. Effect of YAP1 silencing on esophageal cancer.

Authors: Jia Zhao; Xiangnan Li; Yang Yang; Dengyan Zhu; Chunyang Zhang; Donglei Liu; Kai Wu; Song Zhao
Journal: Onco Targets Ther Date: 2016-05-26 Impact factor: 4.147

8. Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells.

Authors: Matthew L Fisher; Daniel Grun; Gautam Adhikary; Wen Xu; Richard L Eckert
Journal: Oncotarget Date: 2017-11-22

Review 9. YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

Authors: Janine S A Warren; Yuxuan Xiao; John M Lamar
Journal: Cancers (Basel) Date: 2018-04-10 Impact factor: 6.639

10. Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers.

Authors: Andreas Marx; Aljoscha Schumann; Doris Höflmayer; Elena Bady; Claudia Hube-Magg; Katharina Möller; Maria Christina Tsourlakis; Stefan Steurer; Franziska Büscheck; Till Eichenauer; Till S Clauditz; Markus Graefen; Ronald Simon; Guido Sauter; Jakob R Izbicki; Hartwig Huland; Hans Heinzer; Alexander Haese; Thorsten Schlomm; Christian Bernreuther; Patrick Lebok; Adam Polonski
Journal: Sci Rep Date: 2020-06-02 Impact factor: 4.379